U S Global Investors Inc. Takes Position in Clorox Company (The) (CLX)

U S Global Investors Inc. bought a new stake in shares of Clorox Company (The) (NYSE:CLX) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 13,400 shares of the company’s stock, valued at approximately $1,768,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Jacobi Capital Management LLC lifted its stake in shares of Clorox by 0.3% during the 2nd quarter. Jacobi Capital Management LLC now owns 1,286 shares of the company’s stock valued at $172,000 after buying an additional 4 shares in the last quarter. Valley National Advisers Inc. lifted its stake in shares of Clorox by 0.6% during the 2nd quarter. Valley National Advisers Inc. now owns 865 shares of the company’s stock valued at $115,000 after buying an additional 5 shares in the last quarter. Bernzott Capital Advisors lifted its stake in shares of Clorox by 0.4% during the 2nd quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock valued at $214,000 after buying an additional 7 shares in the last quarter. Financial Advisory Service Inc. lifted its stake in shares of Clorox by 0.3% during the 2nd quarter. Financial Advisory Service Inc. now owns 4,012 shares of the company’s stock valued at $535,000 after buying an additional 12 shares in the last quarter. Finally, Moors & Cabot Inc. lifted its stake in shares of Clorox by 1.2% during the 2nd quarter. Moors & Cabot Inc. now owns 2,557 shares of the company’s stock valued at $339,000 after buying an additional 30 shares in the last quarter. Institutional investors own 73.42% of the company’s stock.

Shares of Clorox Company (NYSE CLX) opened at $145.23 on Friday. The company has a market cap of $18,725.81, a price-to-earnings ratio of 26.17, a price-to-earnings-growth ratio of 3.95 and a beta of 0.43. Clorox Company has a one year low of $114.07 and a one year high of $145.32. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 EPS for the quarter, topping the consensus estimate of $1.41 by $0.05. The business had revenue of $1.50 billion for the quarter, compared to analysts’ expectations of $1.48 billion. Clorox had a net margin of 11.84% and a return on equity of 161.59%. The business’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.36 EPS. equities analysts forecast that Clorox Company will post 5.6 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Shareholders of record on Wednesday, January 24th will be paid a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 2.31%. The ex-dividend date of this dividend is Tuesday, January 23rd. Clorox’s payout ratio is currently 61.88%.

A number of research firms recently weighed in on CLX. Consumer Edge upgraded shares of Clorox from a “neutral” rating to an “outperform” rating in a research note on Friday, November 10th. BMO Capital Markets restated an “outperform” rating on shares of Clorox in a research note on Tuesday, September 12th. Royal Bank Of Canada restated a “hold” rating and set a $115.00 target price on shares of Clorox in a research note on Sunday, October 8th. Morgan Stanley lowered their target price on shares of Clorox from $138.00 to $128.00 and set an “equal weight” rating on the stock in a research note on Thursday, November 2nd. Finally, Zacks Investment Research upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research note on Monday, November 6th. Two research analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $128.72.

In other news, SVP Michael R. Costello sold 10,574 shares of the company’s stock in a transaction dated Tuesday, November 28th. The shares were sold at an average price of $136.01, for a total transaction of $1,438,169.74. Following the sale, the senior vice president now directly owns 34,867 shares in the company, valued at approximately $4,742,260.67. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The shares were sold at an average price of $130.46, for a total transaction of $2,615,853.46. Following the sale, the senior vice president now owns 10,896 shares in the company, valued at $1,421,492.16. The disclosure for this sale can be found here. 1.00% of the stock is owned by insiders.

COPYRIGHT VIOLATION WARNING: “U S Global Investors Inc. Takes Position in Clorox Company (The) (CLX)” was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.dispatchtribunal.com/2017/12/10/u-s-global-investors-inc-takes-position-in-clorox-company-the-clx.html.

Clorox Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply